Clinical Trial Update: Growth Hormone in Ischemic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating growth hormone in ischemic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Göteborg University | Conditions: Heart Failure, Systolic, Ischemic Heart Disease Chronic | Phase 3 | Status: COMPLETED